Tuesday, October 12, 2021 12:03:38 PM
There is some useful information here:
https://uk.practicallaw.thomsonreuters.com/5-621-1843?transitionType=Default&contextData=(sc.Default)&firstPage=true
The next step is for WLLW to file a statement of defense, likely either taking one of two courses: Making their case for non-infringement, or invalidity.
The court procedures are located here:
https://www.fct-cf.gc.ca/en/pages/representing-yourself/practice-guides/how-to-file-an-action
That details the steps necessary to resolve the matter in court.
WLLW has already stated that they're not infringing and have found a completely novel pathway.
I haven't posted this elsewhere yet... but here's WLLW's patent application for the biosynthesis of cannabinoids:
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2021195517&_cid=P12-KUMNCO-52702-1
That patent application seems to indicate that WLLW is using iterative evolution and mRNA to modify the host cell organism to produce more of a particular molecule given various enzymes.
It looks like Aurora is on a fishing expedition - hilarious that the patent disclosure came out after they filed their statement of claim - could have saved themselves a bit of cash had they known WLLWs method in advance of filing.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM